Applied NeuroSolutions, Inc. (APNS.OB) to Present at OneMedPlace Finance Forum for Emerging Healthcare and Life Science Companies
1/5/2010 10:32:25 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Announces Increased Scope of Alzheimer's Disease Drug Discovery Collaboration With Eli Lilly and Company (LLY) (JOBS); Applied NeuroSolutions Will Receive Up-front Cash Payment of $750,000 and May Receive up to $25.5 Million in Milestone Payments
12/22/2009 8:19:34 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Announces Renewal of Alzheimer's Disease Drug Discovery Collaboration with Eli Lilly and Company (LLY)
12/8/2009 8:53:29 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Updates Promising Results for a Blood-Based Test for Alzheimer's Disease
10/9/2009 6:40:14 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Appoints Craig Taylor as President & CEO
9/1/2009 11:48:59 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Announces Promising Results for a Blood-Based Test for Alzheimer's Disease
7/23/2009 1:24:46 PM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB)’s Renews Agreement with Noted Alzheimer’s Disease Researcher, Peter Davies, Ph.D.
12/22/2008 9:31:23 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB)’s Q3 2008 Alzheimer’s Disease Serum Diagnostic Development Program Update
11/19/2008 8:31:31 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Announces Addition of Healthcare Financial Executive Gary C. Parks to Board of Directors
11/17/2008 9:43:30 AM
More...
|
Applied NeuroSolutions, Inc. (APNS.OB) Announces Addition of Diagnostic Healthcare Executive Edward Ogunro, Ph.D., to Board of Directors
11/3/2008 9:09:00 AM
More...
|
|